BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9625730)

  • 1. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay.
    Breinholt V; Larsen JC
    Chem Res Toxicol; 1998 Jun; 11(6):622-9. PubMed ID: 9625730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types.
    Bovee TF; Helsdingen RJ; Rietjens IM; Keijer J; Hoogenboom RL
    J Steroid Biochem Mol Biol; 2004 Jul; 91(3):99-109. PubMed ID: 15276617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commonly occurring plant flavonoids have estrogenic activity.
    Miksicek RJ
    Mol Pharmacol; 1993 Jul; 44(1):37-43. PubMed ID: 8341277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
    Zava DT; Duwe G
    Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
    Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA
    Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
    Freyberger A; Schmuck G
    Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
    Matsumura A; Ghosh A; Pope GS; Darbre PD
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin-type flavonoids show different estrogenic effects in mammalian and teleost test systems.
    Zierau O; Hamann J; Tischer S; Schwab P; Metz P; Vollmer G; Gutzeit HO; Scholz S
    Biochem Biophys Res Commun; 2005 Jan; 326(4):909-16. PubMed ID: 15607756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells.
    Tamir S; Eizenberg M; Somjen D; Stern N; Shelach R; Kaye A; Vaya J
    Cancer Res; 2000 Oct; 60(20):5704-9. PubMed ID: 11059763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogenic and anticarcinogenic properties of kurarinone, a lavandulyl flavanone from the roots of Sophora flavescens.
    De Naeyer A; Vanden Berghe W; Pocock V; Milligan S; Haegeman G; De Keukeleire D
    J Nat Prod; 2004 Nov; 67(11):1829-32. PubMed ID: 15568770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids.
    Han DH; Denison MS; Tachibana H; Yamada K
    Biosci Biotechnol Biochem; 2002 Jul; 66(7):1479-87. PubMed ID: 12224631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells.
    von Bueren AO; Schlumpf M; Lichtensteiger W
    Anticancer Res; 2008; 28(1A):85-9. PubMed ID: 18383828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica.
    Lee YS; Park JS; Cho SD; Son JK; Cherdshewasart W; Kang KS
    J Vet Sci; 2002 Dec; 3(4):273-7. PubMed ID: 12819377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-sensitive proliferation pattern of cloned Syrian hamster kidney tumor cells.
    Soto AM; Bass JC; Sonnenschein C
    Cancer Res; 1988 Jul; 48(13):3676-80. PubMed ID: 3288332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogenic activity of the chlorinated derivatives of estrogens and flavonoids using a GFP expression system.
    Kuruto-Niwa R; Ito T; Goto H; Nakamura H; Nozawa R; Terao Y
    Environ Toxicol Pharmacol; 2007 Jan; 23(1):121-8. PubMed ID: 21783746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
    Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
    Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities.
    Larrosa M; González-Sarrías A; García-Conesa MT; Tomás-Barberán FA; Espín JC
    J Agric Food Chem; 2006 Mar; 54(5):1611-20. PubMed ID: 16506809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens.
    Boué SM; Wiese TE; Nehls S; Burow ME; Elliott S; Carter-Wientjes CH; Shih BY; McLachlan JA; Cleveland TE
    J Agric Food Chem; 2003 Apr; 51(8):2193-9. PubMed ID: 12670155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.